CCND1 gene amplification in the adenoid cystic carcinoma of the minor salivary glands;Amplificación del gen de la ciclina D1 en los carcinomas adenoides quísticos de glándulas salivares menores

Acta Otorrinolaringologica Espanola

Volumn 55, Issue 2, 2004, Pages 88-92

  Sequeiros Santiago, Guadalupe ^a,c   Rodrigo Tapia, J P ^a,b   Garcia Carracedo D ^b   Garcia Pedrero J ^b   Suarez Nieto C ^a,b   Gonzalez Meana M V ^b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

^c 3 ^*  (Spain)

Author keywords

Adenoid cystic carcinoma; Cyclin D1; Minor salivary glands; Prognosis

Indexed keywords

CYCLIN D1;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MINOR SALIVA GLAND; POLYMERASE CHAIN REACTION; SALIVARY GLAND CARCINOMA; ADULT; AGED; FEMALE; GENETICS; MALE; MIDDLE AGED; PATHOLOGY; SALIVARY GLAND TUMOR;

ADULT; AGED; CARCINOMA, ADENOID CYSTIC; CYCLIN D1; FEMALE; GENE AMPLIFICATION; HUMANS; MALE; MIDDLE AGED; SALIVARY GLAND NEOPLASMS;

EID: 3242715194     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-6519(04)78488-5     Document Type: Article

References (18)

1. Spiro RH, Hooves AG, Strong EW. Adenoid cystic carcinoma: factors influencing survival. Am J Surg 1979; 138:579-83.
2. Fordice J, Kershaw C, El-Naggar A, Goepfert H. Adenoid cystic carcinoma of the head and neck: Predictors of morbiddity and mortality. Arch Otolaryngol Head Neck Surg 1999;125: 149-52.
3. Ortega S, Malumbres M, Barbacid M. Cyclin Ddependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 2002; 1602: 73-78.
4. Schuuring E. The involvement of the chromosome 11q13 region in human ma-lignancies: cyclin D1 and EMS1 are two new candidate oncogenes-a review. Gene 1995; 159:83-96.
5. Rodrigo JP, Garcia LA, Ramos S, Lazo PS, Suarez C. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res 2000; 6: 3177-82.
6. Franzen G, klausen OG, Grenko RT, Carstensen J, Nordenskjold B. Adenoid cystic carcinoma: DNA as a prgnostic indicator. Laryngoscope 1991; 101: 669-73.
7. Xie X, Nordgard S, Halvorsen TB, Franzen G, Boysen M. Prognostic signifycance of nucleolar organizer regions in adenoid cystic carcinomas of the head and neck. Arch Otolaryngol Head Neck Surg 1997; 123: 620-23.
8. Nordgard S, Franzen G, Boysen M, Halvorsen TB. Ki-67 as a pronostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections. Laryngoscope 1997; 107: 531-36.
9. Bang G, Donath K, Thoresen S, Clausen OPF. DNA flow cytometry of reclassified subtypes of malignant salivary glands tumors. J Oral Pathol Med 1994; 23: 291-97.
10. L, Dardick I, Ledin T. Adenoid cystic carcinoma: use of cell proliferation, BCL-2 expression, histologic grade, and clinical stage as predictors of clinical outcome. Head Neck 2000; 22:489-97.
11. Cho K-J, Lee S-S, Lee Y-S. Proliferating cell nuclear antigen and c-erbB-2 oncoprotein expression in adenoid cystic carcinomas of the salivary glands. Head Neck 1999; 21: 414-19.
12. Chiang CP, Chen CH, Liu BY, Sun A, Leu JS, Wang JT. Expression of transforming growth factoralpha in adenoid cystic carcinoma of the salivary gland. J Formos Med Assoc 2001; 100: 471-77.
13. Vered M, Braunstein E, Buchner A. Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin. Head Neck 2002; 24:632-36.
14. Dori S, Trougouboff P, David R, Buchner A. Immunohistochemical evaluation of estrogen and progesterone receptors in adenoid cystic carcinoma of salivary gland origin. Oral Oncol 2000; 36:450-53.
15. Jeng YM, Lin CY, Hsu HC. Expressión of the c.kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett 2000; 154:107-11.
16. Nogueira CP, Dolan RW, Gooey J, Byahatti S, Vaughan CW, Fuleihan NS, et al. Inactivation of p53 and amplifycación of cyclin D1 correlate with clinical outcome in head and neck cancer. Laryngoscope 1998, 108: 345-50.
17. Frierson HF, El-Naggar AK, Welsh, JB, Sapinoso LM, Su AI, Cheng J, et al. Large scale molecular analysis Identifies genes with Altered Expression in Salivary Adenoid Cystic carcinoma. Am J of Pathol 2002; 161: 1315-22.
18. Lammie GA, Fanti V, Smith R, et al. D11s287, a putative oncogen on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to bcl-1. Oncogene 1991; 6: 439-44